ReviewTherapeutic advances in gastroenterology2022

Targeting IL12/23 in ulcerative colitis: update on the role of ustekinumab.

Daniela Pugliese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.